BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 23768171)

  • 1. Curcumin: a boon to colonic diseases.
    Sareen R; Jain N; Pandit V
    Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.
    Basnet P; Skalko-Basnet N
    Molecules; 2011 Jun; 16(6):4567-98. PubMed ID: 21642934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Biological and Pharmacological Properties of an Encapsulated Polyphenol: Curcumin.
    Witika BA; Makoni PA; Matafwali SK; Mweetwa LL; Shandele GC; Walker RB
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
    Aggarwal BB; Sung B
    Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conundrum and therapeutic potential of curcumin in drug delivery.
    Kumar A; Ahuja A; Ali J; Baboota S
    Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of curcumin: problems and promises.
    Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
    Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin entrapped hyaluronan containing niosomes: preparation, characterisation and
    Sadeghi Ghadi Z; Ebrahimnejad P
    J Microencapsul; 2019 Mar; 36(2):169-179. PubMed ID: 31104531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
    Shehzad A; Wahid F; Lee YS
    Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
    Sareen R; Jain N; Rajkumari A; Dhar KL
    Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum.
    Bisht S; Maitra A
    Curr Drug Discov Technol; 2009 Sep; 6(3):192-9. PubMed ID: 19496751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of therapeutic effects of curcumin.
    Noorafshan A; Ashkani-Esfahani S
    Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turmeric: A condiment, cosmetic and cure.
    Gopinath H; Karthikeyan K
    Indian J Dermatol Venereol Leprol; 2018; 84(1):16-21. PubMed ID: 29243674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
    Gugulothu D; Kulkarni A; Patravale V; Dandekar P
    J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
    Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
    Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
    Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
    Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
    Sarkar A; De R; Mukhopadhyay AK
    World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin for chemoprevention of colon cancer.
    Johnson JJ; Mukhtar H
    Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin and curcumin-like molecules: from spice to drugs.
    Marchiani A; Rozzo C; Fadda A; Delogu G; Ruzza P
    Curr Med Chem; 2014; 21(2):204-22. PubMed ID: 23590716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular understanding of curcumin in diabetic nephropathy.
    Soetikno V; Suzuki K; Veeraveedu PT; Arumugam S; Lakshmanan AP; Sone H; Watanabe K
    Drug Discov Today; 2013 Aug; 18(15-16):756-63. PubMed ID: 23651956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
    Mohanty C; Das M; Sahoo SK
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.